Solumedrol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2158 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 38 | 111 | 59 | 6 | 16 | 207 |
| Leukemia | D007938 | — | C95 | 21 | 80 | 28 | 7 | 11 | 130 |
| Syndrome | D013577 | — | — | 17 | 54 | 25 | 17 | 23 | 124 |
| Prostatic neoplasms | D011471 | — | C61 | 12 | 33 | 28 | 6 | 8 | 80 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 7 | 40 | 26 | 9 | 5 | 78 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | 3 | 19 | 22 | 19 | 9 | 70 |
| Lymphoid leukemia | D007945 | — | C91 | 8 | 36 | 19 | 6 | 4 | 67 |
| Covid-19 | D000086382 | — | U07.1 | 2 | 10 | 25 | 7 | 18 | 58 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 11 | 40 | 13 | 1 | 1 | 57 |
| Kidney transplantation | D016030 | — | — | 5 | 19 | 14 | 20 | 3 | 56 |
Show 381 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Graft vs host disease | D006086 | — | D89.81 | 15 | 37 | 16 | — | 7 | 67 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 11 | 34 | 17 | — | 4 | 59 |
| Myelodysplastic syndromes | D009190 | — | D46 | 10 | 39 | 2 | — | 4 | 49 |
| Multiple myeloma | D009101 | — | C90.0 | 10 | 21 | 8 | — | 6 | 44 |
| Preleukemia | D011289 | — | — | 9 | 32 | 2 | — | 4 | 42 |
| Plasma cell neoplasms | D054219 | — | — | 8 | 18 | 8 | — | 6 | 40 |
| Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | 1 | 6 | 8 | — | 7 | 21 |
| Plasmacytoma | D010954 | — | C90.3 | 3 | 9 | 2 | — | 4 | 18 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 7 | 15 | 2 | — | — | 18 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 3 | 14 | 2 | — | — | 18 |
Show 187 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloproliferative disorders | D009196 | — | D47.1 | 5 | 17 | — | — | 2 | 22 |
| Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 1 | 11 | — | — | 2 | 14 |
| T-cell lymphoma | D016399 | — | — | 5 | 10 | — | — | — | 12 |
| T-cell lymphoma peripheral | D016411 | — | — | 4 | 8 | — | — | — | 9 |
| Fanconi anemia | D005199 | Orphanet_84 | D61.03 | 3 | 6 | — | — | 1 | 8 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 7 | — | — | — | 7 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 1 | 5 | — | — | — | 6 |
| Necrosis | D009336 | — | — | — | 5 | — | — | 1 | 6 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 1 | 5 | — | — | — | 6 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 3 | 5 | — | — | — | 6 |
Show 210 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pathologic dilatation | D004108 | — | — | 1 | — | — | — | 4 | 5 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | 1 | — | — | — | 3 | 4 |
| Therapeutic equivalency | D013810 | — | — | 3 | — | — | — | — | 3 |
| Precancerous conditions | D011230 | — | — | 2 | — | — | — | — | 2 |
| Ataxia | D001259 | — | R27.0 | 2 | — | — | — | — | 2 |
| Friedreich ataxia | D005621 | Orphanet_95 | G11.11 | 2 | — | — | — | — | 2 |
| Cerebellar ataxia | D002524 | — | — | 2 | — | — | — | — | 2 |
| Retinal perforations | D012167 | EFO_1001028 | — | 1 | — | — | — | 1 | 2 |
| Tinnitus | D014012 | — | H93.1 | 1 | — | — | — | 1 | 2 |
| Laser therapy | D053685 | — | — | 1 | — | — | — | 1 | 2 |
Show 22 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 3 | 3 |
| Regeneration | D012038 | — | — | — | — | — | — | 3 | 3 |
| Granulomatous mastitis | D058890 | — | N61.2 | — | — | — | — | 2 | 2 |
| Mastitis | D008413 | EFO_1001034 | N61 | — | — | — | — | 2 | 2 |
| Keratoconjunctivitis | D007637 | — | H16.2 | — | — | — | — | 2 | 2 |
| Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 2 | 2 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | — | — | — | 2 | 2 |
| Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | — | 2 | 2 |
| Uveomeningoencephalitic syndrome | D014607 | Orphanet_3437 | H20.82 | — | — | — | — | 2 | 2 |
| Wound healing | D014945 | GO_0042060 | — | — | — | — | — | 2 | 2 |
Show 155 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
144 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use